It is estimated that one in seven men will develop prostate cancer (PCa) in their lifetime and that PCa itself accounts for one in five new cancer diagnoses.1 Invasive removal of prostate tissue is currently required to confirm cancer diagnosis and drive treatment. From these samples, pathologists use the well-characterized Gleason criteria2,3 to interpret histomorphometric features and grade the tissues,4 which can then be used to assign a grade group (GG).5 While these grading criteria have been shown to hold great prognostic value, they are inherently subjective, relying on a pathologist’s interpretation.6